Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Mack    crawled time : 08:20    save search
Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Biomarker-Selected Clinical Trial of MM-121 in Patients with Heregulin Positive Non-Small Cell Lung Cancer
Published: 2015-02-19 (Crawled : 08:20) - globenewswire.com
MACK 4 | $14.72 0.27% 0.27% 76K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
phase 2 lung cancer positive cancer trial mm-120 biomarkers
Merrimack Pharmaceuticals Reports Fourth Quarter 2014 Financial Results
Published: 2015-02-26 (Crawled : 08:20) - globenewswire.com
MACK 4 | $14.72 0.27% 0.27% 76K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
financial results results
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.